Nano-X Imaging Ltd. (NNOX) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Nano-X Imaging Ltd. (NNOX) Healthcare & Pipeline Overview

Nano-X Imaging Ltd. pioneers digital X-ray technology with its Nanox.ARC system and Nanox.CLOUD platform, aiming to democratize medical imaging accessibility. The company's focus on innovative digital MEMS-based X-ray sources positions it within the evolving landscape of medical device technology and teleradiology services.

What Is the Investment Thesis for NNOX?

Nano-X Imaging presents a high-risk, high-reward investment opportunity centered on its disruptive digital X-ray technology. The company's potential lies in its ability to significantly reduce the cost and increase the accessibility of medical imaging through its Nanox.ARC system and Nanox.CLOUD platform. Key value drivers include successful regulatory approvals, manufacturing scalability, and market adoption of its pay-per-scan business model. However, the company's negative profit margin of -576.1% and gross margin of -98.2% highlight significant financial challenges. Upcoming catalysts include continued progress in securing regulatory clearances and partnerships for global deployment. The company's success hinges on overcoming technological hurdles, achieving commercial viability, and navigating a competitive landscape dominated by established players.

Based on FMP financials and quantitative analysis

NNOX Key Highlights

Market capitalization of $50.8M reflects investor sentiment regarding the company's potential in the medical imaging market.

• Negative profit margin of -576.1% indicates substantial ongoing investments in research, development, and commercialization efforts.
• Gross margin of -98.2% suggests that the company's cost of revenue currently exceeds its revenue, highlighting the need for efficient scaling and cost management.
• The company's focus on AI-based software imaging solutions positions it to capitalize on the growing demand for advanced diagnostic tools.
• The Nanox.CLOUD platform aims to disrupt traditional medical screening services by offering a more accessible and cost-effective solution.

Who Are NNOX's Competitors?

NNOX is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are NNOX's Key Strengths?

Innovative digital X-ray technology.

• Potential to reduce the cost of medical imaging.
• Integrated cloud-based platform.
• AI-based software solutions.

What Are NNOX's Weaknesses?

Negative profit and gross margins.

• Dependence on regulatory approvals.
• Limited commercial track record.
• Competition from established players.

What Could Drive NNOX Stock Higher?

Potential FDA clearance for the Nanox.ARC system.

• Expansion of strategic partnerships with healthcare providers.
• Development and commercialization of AI-based software solutions.

What Are the Key Risks for NNOX?

Listing risk — at $0.7301 the shares sit below the $1.00 minimum bid NASDAQ requires for continued listing.

• Financial-distress signal — its Altman Z-Score of -9.42 sits in the distress zone (elevated bankruptcy risk).
• Negative return on equity (-51.9%) — the business is not currently generating profit on shareholder capital.
• Delays in regulatory approvals for the Nanox.ARC system.
• Technological challenges in scaling up production.
• Competition from established players in the medical imaging industry.
• Financial risks associated with negative profit and gross margins.

What Are the Growth Opportunities for NNOX?

• Global Expansion: Nano-X Imaging has the opportunity to expand its market reach globally, particularly in underserved regions with limited access to medical imaging. By partnering with local healthcare providers and governments, the company can deploy its Nanox.ARC system and Nanox.CLOUD platform to improve healthcare access and outcomes. The global market for X-ray imaging is expected to grow, presenting a substantial opportunity for Nano-X Imaging to capture market share through strategic partnerships and targeted marketing efforts. Timeline: Ongoing.
• Teleradiology Services: The increasing demand for remote image interpretation services presents a significant growth opportunity for Nano-X Imaging. By expanding its teleradiology services, the company can generate recurring revenue and enhance its value proposition to healthcare providers. The global teleradiology market is projected to experience substantial growth, driven by factors such as shortage of radiologists and the need for faster and more efficient image interpretation. Timeline: Ongoing.
• AI-Based Software Solutions: Nano-X Imaging can leverage its AI-based software solutions to improve the accuracy and efficiency of medical diagnosis. By developing and commercializing AI algorithms for detecting and predicting medical conditions, the company can generate additional revenue streams and enhance its competitive advantage. The market for AI in healthcare is rapidly growing, driven by the increasing availability of medical data and the advancements in AI technology. Timeline: Ongoing.
• Strategic Partnerships: Forming strategic partnerships with hospitals, HMOs, and pharmaceutical companies can accelerate the adoption of Nano-X Imaging's technology and expand its market reach. By collaborating with established players in the healthcare industry, the company can gain access to new customers, distribution channels, and resources. Strategic partnerships can also help Nano-X Imaging validate its technology and build credibility in the market. Timeline: Ongoing.
• Nanox.MARKETPLACE Expansion: Expanding the Nanox.MARKETPLACE to include a broader range of services and features can attract more users and generate additional revenue. By offering a comprehensive platform for medical imaging services, Nano-X Imaging can create a network effect and establish itself as a leading provider of medical imaging solutions. The Nanox.MARKETPLACE has the potential to become a valuable resource for healthcare providers and patients, driving adoption and growth. Timeline: Ongoing.

What Threats Does NNOX Face?

• Technological obsolescence.
• Regulatory hurdles and delays.
• Competition from established players.
• Economic downturn affecting healthcare spending.

What Are NNOX's Competitive Advantages?

• Proprietary digital X-ray source technology based on MEMS.
• Integrated Nanox.CLOUD platform for cloud-based medical services.
• Nanox.MARKETPLACE connecting imaging facilities with radiologists.
• AI-based software solutions for medical diagnosis.

What Does NNOX Do?

Founded in 2011 and headquartered in Neve Ilan, Israel, Nano-X Imaging Ltd. is dedicated to transforming the medical imaging industry through its innovative digital X-ray technology. The company's core product, the Nanox.ARC, is a tomographic imaging device that utilizes a proprietary digital micro-electro-mechanical systems (MEMS) semiconductor cathode as its X-ray source. This technology aims to offer a cost-effective and accessible alternative to traditional analog X-ray systems. Complementing the Nanox.ARC is the Nanox.CLOUD, a cloud-based software platform designed to facilitate the delivery of medical screening as a service. This platform integrates with the Nanox.MARKETPLACE, connecting imaging facilities with radiologists for remote image interpretation. Nano-X Imaging also develops AI-based software solutions intended for hospitals, HMOs, and pharmaceutical companies, designed to identify or predict medical conditions from existing CT scans. These solutions target conditions like osteoporosis and cardiovascular disease. Furthermore, the company provides teleradiology services, offering image interpretation for radiology practices, hospitals, and urgent care facilities. Nano-X Imaging's business model centers around making medical imaging more readily available and affordable, particularly in underserved communities and regions with limited access to advanced healthcare technologies. The company is currently focused on obtaining regulatory approvals and scaling up production to commercialize its Nanox.ARC system globally.

What Products and Services Does NNOX Offer?

• Develops a digital X-ray source-based medical imaging system.
• Provides teleradiology services for remote image interpretation.
• Creates AI-based software solutions for medical diagnosis.
• Offers the Nanox.ARC system for accessible medical screening.
• Operates the Nanox.CLOUD platform for cloud-based medical services.
• Connects imaging facilities with radiologists through Nanox.MARKETPLACE.

How Does NNOX Make Money?

• Sells or leases the Nanox.ARC system to healthcare providers.
• Generates revenue from pay-per-scan usage of the Nanox.ARC system.
• Provides teleradiology services for a fee.
• Licenses AI-based software solutions to hospitals and pharmaceutical companies.

What Industry Does NNOX Operate In?

Nano-X Imaging operates within the medical devices industry, specifically targeting the diagnostic imaging segment. The industry is characterized by technological innovation, stringent regulatory requirements, and a growing demand for advanced imaging solutions. Market trends include the increasing adoption of digital X-ray technology, the rise of teleradiology, and the integration of artificial intelligence in medical imaging. Nano-X Imaging aims to disrupt the traditional X-ray market by offering a more affordable and accessible solution. The company faces competition from established players in the medical imaging industry, as well as emerging companies developing innovative imaging technologies. The global medical imaging market is projected to reach significant growth in the coming years, driven by factors such as an aging population, increasing prevalence of chronic diseases, and advancements in imaging technology.

Who Are NNOX's Key Customers?

• Hospitals and medical clinics.
• Radiology practices and diagnostic imaging centers.
• Health maintenance organizations (HMOs).
• Pharmaceutical companies.

Over the past six months, Nano-X Imaging Ltd. insiders filed 9 SEC Form 4 transactions — 3 sales and 6 purchases. On net that is roughly 166K shares acquired (about $117K) — insiders putting money in tends to read as conviction.

Quarterly Financial Performance: Nano-X Imaging Ltd.

Revenue for Nano-X Imaging Ltd. came in at $4.2M during Q2 FY2026, a 3.6% contraction versus the preceding quarter. The company recorded a net loss of $55.5M, with diluted EPS of $-0.79. Quarter-over-quarter revenue has been mixed, typical for a micro-cap company operating in Healthcare. Across the four most recent quarters, NNOX averaged $-0.42 in diluted EPS.

NNOX Valuation & Market Position

With a $50.8M market cap, Nano-X Imaging Ltd. sits in the micro-cap segment of the market. Analyst price targets span from $3.00 to $3.00, with a consensus of $3.00. At the current price of $0.73, that implies approximately 311% upside potential. Relative to its peer group, NNOX's quantitative score of 18/100 is below the peer average of 51/100.

Return on equity for Nano-X Imaging Ltd. stands at -51.9%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -52.2%, showing how much profit it generates from its asset base. Its free cash flow yield is -54.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 3.64 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -80.3%, the inverse of the P/E and a quick read on earnings relative to price.

Nano-X Imaging Ltd.'s Piotroski F-Score is 2/9, a 9-point checklist of profitability, leverage and efficiency — flagging fundamental weakness worth scrutiny. Its Altman Z-Score of -9.42 places it in the distress zone, a signal of elevated financial risk.

Nano-X Imaging Ltd. has missed Wall Street's EPS estimate in 7 of its last 8 reported quarters — a recurring pattern of falling short of estimates. Reported results have landed about 74.3% below estimates on average.

Company Profile

Nano-X Imaging Ltd. operates in the Medical - Devices industry within the Healthcare sector. It is headquartered in Petah Tikva, IL. The company is led by CEO Erez I. Meltzer. NNOX has traded publicly since 2020.

NNOX Financials

NNOX Latest News

NNOX Analyst Consensus

NNOX MoonshotScore

What Investors Ask About Nano-X Imaging Ltd. (NNOX) — Healthcare

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources